Abstract 5322: Discovery of CRD1601, a potent and selective HPK1 inhibitor with robust in vivo anti-cancer activity
Banerjee, Monali, Shrivastava, Ritesh, Pryde, David, Middya, Sandip, Debnath, Sabyasachi, Middya, Anindita, Yadav, Dharmendra, Rawat, Nidhi, Ghosh, Rajib, Padaliya, Manisha, Basu, Sourav, Surya, Arjun
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article
Abstract 3510: Small molecule ACSS2 inhibitors target acetate metabolizing tumor cells in hypoxic conditions
Banerjee, Monali, Basu, Sourav, Chakraborty, Debjani, Shrivastava, Ritesh, Middya, Sandip, Ghosh, Rajib, Yadav, Dharmendra, Sinha, Arghyotri, Das, Avratanu, Pandit, Navin, Naiya, Mohinder, Debnath, Sabyasachi, Dey, Sangeeta, Dasgupta, Debottam, Das, Nirmal, Singh, Anuj, Sarkar, Dipayan, Sarkar, Sukanya, Narasipuram, Ganesh, Mane, Nagaswami, Singhal, Nicky, Rawat, Nidhi, Middya, Anindita, Surya, Arjun
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Abstract 2122: CRD1600 is a potent HPK-I inhibitor with robust immune modulatory properties
Shrivastava, Ritesh, Pryde, David C., Yadav, Dharmendra, Chatterjee, Abhisek, Middya, Sandip, Shaikh, Sameer, Ghosh, Rajib, Debnath, Sabyasachi, Mane, Nagaswamy, Middya, Anindita, Rawat, Nidhi, Gautam, Anuj, Basu, Sourav, Banerjee, Monali, Surya, Arjun
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article
HETEROCYCLIC INHIBITORS OF CDC-LIKE KINASES
PRYDE, David Cameron, GHOSH, Rajib, DEBNATH, Sabyasachi, YADAV, Dharmendra B, SHRIVASTAVA, Ritesh Kumar, BANERJEE, Monali, MIDDYA, Sandip Kumar, BASU, Sourav, SURYA, Arjun
Year of Publication 23.05.2024
Get full text
Year of Publication 23.05.2024
Patent